Aesku NY Overview
- Founded
-
2003
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Aesku NY General Information
Description
Developer of a screening technology intended for connective tissue disorders such as lupus. The company provides test methods for the detection of autoantibodies for connective tissue and other autoimmune disorders, enabling clinicians to detect patients with diseases and provide treatments accordingly.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Services
Primary Office
- Buffalo, NY
- United States
Aesku NY Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 05-Jun-2014 | Completed | Generating Revenue | |||
| 1. Spin-Off | 01-Jan-2003 | Completed | Generating Revenue |
Aesku NY Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Vijay Kumar Ph.D | Vice President & Chief Operating Officer |
Aesku NY Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Aesku NY Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Start-up NY | Accelerator/Incubator | 000 0000 | 000000 0 |